Which Stock Is Better? Arch Coal Inc (ACI) and Harvard Bioscience Inc (HBIO)

Posted by admin March 27, 2015 0 Comment 939 views


New York, NY – GDP INSIDER  –  03/27/2015.

This article discusses two companies: Arch Coal Inc (NYSE:ACI) and Harvard Bioscience Inc (NASDAQ:HBIO)

Arch Coal Inc (NYSE:ACI) fell back again yesterday with the stock sliding 4.34% or $0.05 to close at $0.99 with more than 4.147 million shares changing hands, compared to its three month average trading volume of 5.038 million. The supplier of cleaner burning metallurgical coal for power generators has been trending down for the last 52 weeks, with the shares price now 78.10% lower for the period and down 44.06% so far this year. The latest fall came on the back of reports of warmer weather in the Midwest combined with a U.S. Energy Information Administration (EIA) report that natural gas production is still increasing. As natural gas prices fall, it negatively impacts coal prices, as gas is a cheaper alternative to coal. However, Arch Coal Inc is fighting back by striving hard to cut costs and has suspended its dividend to maintain liquidity. Even so, the stock is better to sell than hold.

Does Arch Coal Inc Have Potential In The Medium Term? Take A Look At The Technical Indicators In Our Free ACI Analysis.

Harvard Bioscience Inc (NASDAQ:HBIO) continued to climb yesterday with the stock gaining another 1.10% or $0.06 to close at $5.49 on very active trading volume of 0.767 million shares, compared to its three month average trading volume of 0.099 million. The developer and manufacturer of scientific instruments and apparatus has been fluctuating between $5.15 and $5.83 over the last month, after it released very positive fourth quarter and full year financial results at the end of February. Despite these recent gains, Harvard Bioscience Inc has been underperforming the S&P 500 so far this year, with the stock losing 3.16% YTD, compared to the S&P 500 which has only lost 0.13% over the same period. With quarterly revenue growth of 9.00% year on year and a bullish MACD crossover looking likely, the stock should still continue to rise and get closer to its one year target estimate of $8.03, making it a hold and potential buy.

Can Harvard Bioscience Inc Maintain Its Upward Trend ? Click Here For Free HBIO Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment